Jairo Wagner
Overview
Explore the profile of Jairo Wagner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campos Neto G, Junior E, Weltman E, Malheiros S, Ferrari B, Vitor T, et al.
Einstein (Sao Paulo)
. 2022 Nov;
20:eAO0104.
PMID: 36449758
Objective: To evaluate whether there is a significant difference in somatostatin analog uptake in meningiomas treated or not with radiation therapy. Methods: A cross-sectional study was performed comparing measurements of...
2.
Reis M, Gadelha A, Felicio A, Hoexter M, Batista I, Braga-Neto P, et al.
Medicine (Baltimore)
. 2021 Oct;
100(39):e27192.
PMID: 34596116
The presynaptic dopamine transporter (DAT) modulates the uptake of dopamine by regulating its concentration in the central nervous system. We aimed to evaluate the DAT binding potential (DAT-BP) in a...
3.
Afshar-Oromieh A, da Cunha M, Wagner J, Haberkorn U, Debus N, Weber W, et al.
Eur J Nucl Med Mol Imaging
. 2021 Feb;
48(9):2925-2934.
PMID: 33543325
Purpose: To evaluate the performance of [Ga]Ga-PSMA-11 PET/CT in the diagnosis of recurrent prostate cancer (PC) after prostatectomy in a large multicentre cohort. Methods: The centres, which contributed to this...
4.
Scheinberg M, Maluf F, Wagner J
Ann Rheum Dis
. 2020 May;
79(9):1259-1260.
PMID: 32381566
No abstract available.
5.
Serrano Uson Junior P, Wagner J, de Nigro Corpa M, Coelho I, Nagourney R, Yamaguchi N
SAGE Open Med Case Rep
. 2019 Mar;
7:2050313X19838739.
PMID: 30915220
Background: The treatment of carcinoma of unknown primary based on histopathology and immunohistochemistry is generally chemotherapy. The use of molecular markers, genetic profiling platforms, and personalized medicine is under active...
6.
Yang J, Maciel R, Nakabashi C, Janovsky C, Padovani R, Macellaro D, et al.
Arch Endocrinol Metab
. 2017 Oct;
61(5):416-425.
PMID: 28977157
Objective: To evaluate the clinical utility of 18F-FDG PET/CT in patients with high-risk DTC. Subjects And Methods: Single-center retrospective study with 74 patients with high-risk differentiated thyroid cancer (DTC), classified...
7.
Yang J, Camacho C, Lindsey S, Valente F, Andreoni D, Yamaga L, et al.
Endocr Pract
. 2017 Jun;
23(8):942-948.
PMID: 28614009
Objective: Calcitonin and carcinoembryonic antigen (CEA) doubling times are established prognostic markers in medullary thyroid cancer (MTC). On the other hand, F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) shows an...
8.
Vitor T, Carvalho Neto G, Nogueira S, Wagner J, Felicio A
Arq Neuropsiquiatr
. 2017 May;
75(4):258-259.
PMID: 28489148
No abstract available.
9.
Vitor T, Martins K, Ionescu T, da Cunha M, Baroni R, Garcia M, et al.
Einstein (Sao Paulo)
. 2017 Apr;
15(1):115-118.
PMID: 28444102
In recent years, medical imaging with hybrid techniques has widely accepted and employed in clinical routine. PET/MRI offers significant advantages, including excellent contrast and resolution and reduced ionizing radiation, as...
10.
Yamaga L, Cunha M, Campos Neto G, Garcia M, Yang J, Camacho C, et al.
Eur J Nucl Med Mol Imaging
. 2017 Apr;
44(10):1695-1701.
PMID: 28429044
Purpose: The aim of this study was to prospectively compare the detection rate of Ga-DOTATATE PET-CT with In-octreotide SPECT-CT and conventional imaging (CI) in medullary thyroid carcinoma (MTC) patients with...